Exchange: NASDAQ·Updated 07:32 PM EST

FRNM Freenome, Inc.

$9.44
$0.565
(5.69%)
Today
Closed $9.36
$0.08
(0.85%)
After Hours
Mkt Cap$1.04B
Vol621,755.00

About FRNM

Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.
37

Bearish Sentiment

How do you feel about FRNM?

Advertisement|Remove ads.